<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02335229</url>
  </required_header>
  <id_info>
    <org_study_id>20-SMI-2013</org_study_id>
    <nct_id>NCT02335229</nct_id>
  </id_info>
  <brief_title>A Post Market Study to Assess the Spinal Modulation Dorsal Root Ganglion Stimulator System in Chronic Post Surgical Pain</brief_title>
  <official_title>A Post Market Observational Cohort Study to Assess the Performance of the Spinal Modulation Dorsal Root Ganglion Stimulator System for the Management of Chronic Post Surgical Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Jude Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Jude Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      20-SMI-2013 is a post market, observational, questionnaire based study to assess the
      effectiveness of the commercially available Axium neurostimulator in the management of
      chronic post surgical pain
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Actual">February 2017</completion_date>
  <primary_completion_date type="Actual">February 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Relief - Assessed by Change in Pain Intensity from Pre-Treatment Baseline</measure>
    <time_frame>Post implantation at; 1 week and 1, 3, 6, 12 and 24 months</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">30</enrollment>
  <condition>Chronic Post Surgical Pain</condition>
  <arm_group>
    <arm_group_label>Treated Subjects</arm_group_label>
    <description>All eligible subjects recruited and treated with the Axium Neurostimulator</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Implantation with the commercially available Axium Neurostimulator</intervention_name>
    <arm_group_label>Treated Subjects</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient suffering from chronic post surgical pain
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject is at least 18 years old

          2. Subject is able and willing to comply with the follow-up schedule and protocol

          3. Chronic post surgical pain for at least 6 months

          4. Failed conservative treatments for chronic pain including but not limited to
             pharmacological therapy, physical therapy and interventional pain procedures for
             chronic pain

          5. Minimum baseline pain rating of 60 mm on the Visual Analog Scale in the primary region
             of pain

          6. Subject is able to provide written informed consent

          7. Pain medication dosage has been stable for at least 30 days

          8. Patient has been included for implantation according to standard criteria from the
             Dutch Neuromodulation Society

        Exclusion Criteria:

          1. Female subject of childbearing potential is pregnant/nursing, plans to become pregnant
             or is unwilling to use approved birth control

          2. Escalating or changing pain condition within the past month as evidenced by
             investigator examination

          3. Subject has had corticosteroid therapy at an intended site of stimulation within the
             past 30 days

          4. Subject has had radiofrequency treatment of an intended target Dorsal Root Ganglion
             within the past 3 months

          5. Subject currently has an active implantable device including implantable cardioverter
             defibrillator, pacemaker, spinal cord stimulator or intrathecal drug pump

          6. Subject is unable to operate the device

          7. Subjects with indwelling devices that may pose an increased risk of infection

          8. Subjects currently has an active infection

          9. Subject has participated in another clinical investigation within 30 days

         10. Subject has a coagulation disorder or uses anticoagulants that, in the opinion of the
             investigator, precludes participation

         11. Subject has been diagnosed with cancer in the past 2 years.

         12. Patient has no other exclusion criteria according to standard criteria from the Dutch
             Neuromodulation Society
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Academisch Medisch Centrum</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 7, 2015</study_first_submitted>
  <study_first_submitted_qc>January 7, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 9, 2015</study_first_posted>
  <last_update_submitted>April 24, 2017</last_update_submitted>
  <last_update_submitted_qc>April 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <pending_results>
    <submitted>September 14, 2017</submitted>
    <returned>November 3, 2017</returned>
    <submitted>November 13, 2017</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

